Kronos Bio Inc
Biotechnology
Healthcare
KRON
57.40 M shares
NASDAQ US
traded
18 Dec 2023
listed
no
open
1.46
52 week high
5.38
high
1.51
52 week low
1.32
low
1.36
growth
-2.01 %
previous Close
1.49
P/E ratio
market cap
88.75 M
div yield
0
usd
Jun 2023
qoq
revenue
1.86 M
52.66 %
net incoming
-29.74 M
-27.02 %
eps
0.00 %
-13.04 %
eps surprise
-13.04 %
net profit margin
-1595.55 %
322.00 %
operating incoming
-32.17 M
-12.90 %
net change in cash
-19.28 M
-56.68 %
cash on hand
44.40 M
-27.98 %
cost of revenue
0.00 %
top top